$COTY

Gucci and L'Oréal conclude a 50-year beauty licensing agreement

Kering said Gucci’s beauty licensing deal with Coty ends early, with Coty paying about $400 million. Kering will receive payments in 2026 ($250 million) and 2027 (up to $150 million). L’Oréal’s new Gucci beauty license is expected to start mid-2027, following a 2025 framework for L’Oréal to buy Kering’s beauty division for 4 billion euros.

Original reporting
Published Jul 8, 2026, 2:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 2:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Gucci and L'Oréal conclude a 50-year beauty licensing agreement — source image
Decision brief

The 30-second read

$COTYNeutralMed
01

Why it matters

The newest disclosed facts are the early termination of Gucci’s beauty license by Coty for about $400M, the mid-2027 effective date for L’Oréal, and cost/inventory sharing mechanics between L’Oréal and Kering.

02

Market read

This is a concrete licensing and transition-cost update that can shift cash-flow expectations and risk perception for Coty, L’Oréal, and Kering.

03

What to watch

The article does not quantify how the transition affects royalty rates, inventory write-downs, or segment margins for each party, which could dominate equity reaction.

Relevance 7/10Novelty 7/10Timing: deal transition expected to take effect mid-2027; Coty payments in 2026 and 2027

Background

Kering’s Gucci beauty licensing was previously tied up with Coty, delaying a 2025 L’Oréal-Kering beauty division transaction.

Company-level read

Ticker impact

$COTYNeutralMedium confidence
Context

Coty will relinquish Gucci’s beauty license early for about $400 million, with payments scheduled across 2026 and 2027.

Expected impact

Moderate, likely limited unless investors view the $400M as offsetting margin pressure or signaling broader brand exit risk.

Evidence & confidence

The article discloses deal value and payment timing but not Coty’s financial impact, guidance, or segment margin details.

Market effects

Signals ongoing consolidation and portfolio reshuffling in luxury beauty licensing, potentially affecting how investors underwrite brand royalty streams.

Primarily impacts European luxury and cosmetics equities, with potential sentiment spillover to other brand-licensing models.

Reinforces the global luxury beauty licensing framework and may influence expectations for future royalty and transition-cost structures.

Counterpoint

The $400M early termination may be viewed as a one-off cash item that does not resolve underlying Gucci beauty demand weakness.

Key entities

  • Gucci

    Luxury fashion brand whose beauty licensing is being transferred and terminated early under the new agreement.

  • Coty

    Beauty company relinquishing Gucci’s beauty license early for approximately $400M.

  • L’Oréal

    Cosmetics company receiving the Gucci beauty license, expected to take effect mid-2027.

  • Kering

    Owner of Gucci, receiving about $400M from Coty and selling its beauty division to L’Oréal for 4 billion euros.

Related articles

$COTYMed

Analysis-No Gucci, no problem? Coty learns to live without flagship brand By Reuters

Reuters reports Coty will exit its Gucci Beauty licence a year early under a $400 million deal, returning the licence to Kering in mid-2027. Coty estimates it will forgo about $115 million annual adjusted EBITDA (15%), but expects $250 million upfront plus $150 million later to cut net debt (~$2.9B) and reduce costs. Barclays and analysts cite margin pressure but less Gucci dependence.

$COTYMedAI 8/10

Luxury retailer exits beauty business and ends major partnership

Kering (PPRUY) said Gucci and L’Oréal (LRLCY) will start a 50-year exclusive beauty licensing deal in mid-2027, replacing Gucci’s current Coty (COTY) license that was set to run until June 30, 2028. Coty will receive about $400 million for early termination. Kering expects proceeds to support deleveraging after weaker performance, with net debt €9.5 billion at end-June 2025.

$COTYMed

Gucci Beauty License Shift to L’Oréal: Analysts Weigh Impact on Coty’s Future

Coty Inc. said it will end its Gucci Beauty fragrance and license early, with L’Oréal taking over a 50-year exclusive beauty license effective mid-2027. Coty will receive about $400 million in two payments ($250 million this year, up to $150 million in 2027). Analysts at Jefferies and Barclays weigh impacts on Coty’s EBITDA estimates and note the next update is due with Q4 earnings.

$COTYMedAI 8/10

Coty exits Gucci license early

Coty agreed to return the Gucci Beauty license to Kering about a year early for about $400 million, ending its current contract. Coty will use most proceeds to pay down debt and invest in brands like BOSS and Marc Jacobs. Deal terms include $250 million upfront, $150 million by Sept. 30, 2027, and up to $30 million incentives. Coty continues operating Gucci Beauty through June 30, 2027.

$COTYMedAI 8/10

Coty Announces Agreement With Kering for Early Transition of Gucci Beauty License

Coty (NYSE: COTY) said it agreed with Kering to transition the Gucci Beauty license back to Kering about a year early. Coty will receive about $400 million, including $250 million at signing and $150 million by Sept. 30, 2027, plus a sale of inventory for the transition. Coty will run Gucci Beauty through at least June 30, 2027; proceeds will support debt paydown and reinvestment.